Greater Cannabis Company (GCAN) Preferred Shares (2018 - 2026)
Greater Cannabis Company's (GCAN) quarterly Preferred Shares came in at $9112.0 in Q1 2026, little changed year-on-year from $9112.0 in Q1 2025, and up 911100.0% quarter-over-quarter from $1.0 in Q4 2025.
Greater Cannabis Company (GCAN) Preferred Shares (2018 - 2026) Analysis & Trends
Greater Cannabis Company's Preferred Shares history runs 9 years deep, the most recent figure standing at $9112.0 for Q1 2026.
- On a quarterly basis, Preferred Shares changed 0.0% year-over-year to $9112.0 in Q1 2026; TTM through Mar 2026 was $9112.0, a 0.0% change from a year earlier, with the FY2025 full-year figure at $1.0, down 99.99% from the prior year.
- Preferred Shares grew to $9112.0 in Q1 2026 per GCAN's latest filing, from $1.0 in the prior quarter.
- Across five years, Preferred Shares topped out at $9112.0 in Q1 2022 and bottomed at $1.0 in Q4 2025.
- The 5-year median for Preferred Shares is $9112.0 (2022), against an average of $8576.1.
- Across the five-year window, Preferred Shares changed 0.0% in 2022 and plunged 99.99% in 2025, its largest moves.
- Year by year, Preferred Shares stood at $9112.0 in 2022, then changed by 0.0% to $9112.0 in 2023, then changed by 0.0% to $9112.0 in 2024, then plunged by 99.99% to $1.0 in 2025, then surged by 911100.0% to $9112.0 in 2026.
- Per Business Quant, the three latest GCAN Preferred Shares figures stand at $9112.0 (Q1 2026), $1.0 (Q4 2025), and $9112.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Greater Cannabis Company | 292,929.85 | 292,929.85 | - | 9,112.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9,112.00 |
| Dec 31, 2025 | 1.00 |
| Sep 30, 2025 | 9,112.00 |
| Jun 30, 2025 | 9,112.00 |
| Mar 31, 2025 | 9,112.00 |
| Dec 31, 2024 | 9,112.00 |
| Sep 30, 2024 | 9,112.00 |
| Jun 30, 2024 | 9,112.00 |
| Mar 31, 2024 | 9,112.00 |
| Dec 31, 2023 | 9,112.00 |
| Sep 30, 2023 | 9,112.00 |
| Jun 30, 2023 | 9,112.00 |
| Mar 31, 2023 | 9,112.00 |
| Dec 31, 2022 | 9,112.00 |
| Sep 30, 2022 | 9,112.00 |
| Jun 30, 2022 | 9,112.00 |
| Mar 31, 2022 | 9,112.00 |
| Dec 31, 2021 | 9,112.00 |
| Sep 30, 2021 | 9,112.00 |
| Jun 30, 2021 | 9,412.00 |